Your browser doesn't support javascript.
loading
Validity of the global anti-phospholipid syndrome score to predict thrombosis: a prospective multicentre cohort study.
Zuily, Stéphane; de Laat, Bas; Mohamed, Shirine; Kelchtermans, Hilde; Shums, Zakera; Albesa, Roger; Norman, Gary L; Lamboux-Matthieu, Claire; Rat, Anne-Christine; Ninet, Jacques; Magy-Bertrand, Nadine; Pasquali, Jean-Louis; Lambert, Marc; Lorcerie, Bernard; Kaminsky, Pierre; Guillemin, Francis; Regnault, Véronique; Wahl, Denis.
Afiliação
  • Zuily S; CHU de Nancy, Regional Competence Centre for Rare Vascular and Systemic Autoimmune Diseases, Vascular Medicine Division, Inserm, UMRS 1116, Nancy School of Medicine, Université de Lorraine, Nancy, France, s.zuily@chu-nancy.fr.
  • de Laat B; Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, Clinical Chemistry and Haematology, University Medical Centre Utrecht, Synapse BV, Maastricht, Department of Plasma Proteins/Blood coagulation, Sanquin Research, Amsterdam, The Netherlands.
  • Mohamed S; Nancy School of Medicine, Université de Lorraine, Nancy, France, CHU de Nancy, Orphan Disease Unit, Nancy, France.
  • Kelchtermans H; Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht.
  • Shums Z; Research and Development, Inova Diagnostics, San Diego, CA, USA.
  • Albesa R; Research and Development, Inova Diagnostics, San Diego, CA, USA.
  • Norman GL; Research and Development, Inova Diagnostics, San Diego, CA, USA.
  • Lamboux-Matthieu C; CHU de Nancy, Regional Competence Centre for Rare Vascular and Systemic Autoimmune Diseases, Vascular Medicine Division.
  • Rat AC; Université de Lorraine, Paris Descartes University, APEMAC, EA 4360, Inserm, CIC-EC 1433, CHU de Nancy, Clinical Epidemiology and Evaluation Department, CHU de Nancy, Rheumatology Department, Nancy.
  • Ninet J; CHU de Lyon, Department of Internal Medicine, Lyon.
  • Magy-Bertrand N; CHRU de Besançon, Internal Medicine Department, Besançon.
  • Pasquali JL; CHU de Strasbourg, Internal Medicine and Clinical Immunology Department, Strasbourg, F-67000.
  • Lambert M; CHRU de Lille, Department of Internal Medicine, Lille.
  • Lorcerie B; CHU de Dijon, Internal Medicine and Clinical Immunology Department, Dijon and.
  • Kaminsky P; Nancy School of Medicine, Université de Lorraine, Nancy, France, CHU de Nancy, Orphan Disease Unit, Nancy, France.
  • Guillemin F; Université de Lorraine, Paris Descartes University, APEMAC, EA 4360, Inserm, CIC-EC 1433, CHU de Nancy, Clinical Epidemiology and Evaluation Department.
  • Regnault V; Inserm, UMRS 1116, CHU de Nancy, Contrat d'interface, Nancy, France.
  • Wahl D; CHU de Nancy, Regional Competence Centre for Rare Vascular and Systemic Autoimmune Diseases, Vascular Medicine Division, Inserm, UMRS 1116, Nancy School of Medicine, Université de Lorraine, Nancy, France.
Rheumatology (Oxford) ; 54(11): 2071-5, 2015 Nov.
Article em En | MEDLINE | ID: mdl-26163690
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombose / Índice de Gravidade de Doença / Síndrome Antifosfolipídica Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombose / Índice de Gravidade de Doença / Síndrome Antifosfolipídica Idioma: En Ano de publicação: 2015 Tipo de documento: Article